Predictive value of the CES-D in detecting depression among candidates for disease-modifying multiple sclerosis treatment.
The presence of depression is an important concern for patients with multiple sclerosis who are candidates for disease-modifying treatment, since depression may affect treatment adherence. The authors evaluated the positive predictive value of the Center for Epidemiologic Studies Depression Rating Scale (CES-D) in detecting depression among patients who were candidates for disease-modifying multiple sclerosis treatment. Of 47 patients who scored >/=16 on the CES-D, 74.5% (N=38) were found to have a depressive disorder. The results of the study indicate that case-finding for depressive disorders among multiple sclerosis patients can be facilitated by use of the CES-D scale.
Pandya
Rupang
R
Psychiatry Administration, Department of Psychiatry, University of Calgary, 1403 29th St., NW, Calgary, ALB T3H 2R9, Canada. ruppandya@hotmail.com
Metz
Luanne
L
Patten
Scott B
SB
D000293:Adolescent; D000328:Adult; D003865:Major Depressive Disorder / Q000175:diagnosis* / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000453:epidemiology*; D015588:Observer Variation; D010349:Patient Compliance; D018579:Patient Selection; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires